Skip to main content
Fig. 4 | BMC Pulmonary Medicine

Fig. 4

From: Comprehensive analysis pinpoints CCNA2 as a prognostic and immunological biomarker in non-small cell lung cancer

Fig. 4

The diagnostic and prognostic value of CCNA2 in NSCLC patients. The ROC curves of CCNA2 for the diagnosis of LUAD (A) and LUSC (B). The OS curves of CCNA2 in prognosis of LUAD (C) and LUSC (D). (E) The univariate and multivariate Cox regression analysis of CCNA2 in LUAD. (F) Nomogram of CCNA2, smoker, TNM, and age in LUAD to predict the 1-year, 3-year, and 5-year survival. (G) Calibration curve to validate the accuracy of the nomogram

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us